ATE225183T1 - Verwendung von hepatozyten-wachstumsfaktor zur induzierung der proliferation und differenzierung von hämatopoietischen zellen - Google Patents

Verwendung von hepatozyten-wachstumsfaktor zur induzierung der proliferation und differenzierung von hämatopoietischen zellen

Info

Publication number
ATE225183T1
ATE225183T1 AT95941620T AT95941620T ATE225183T1 AT E225183 T1 ATE225183 T1 AT E225183T1 AT 95941620 T AT95941620 T AT 95941620T AT 95941620 T AT95941620 T AT 95941620T AT E225183 T1 ATE225183 T1 AT E225183T1
Authority
AT
Austria
Prior art keywords
growth factor
differentiation
pct
hepatocyte growth
hematopoietic cells
Prior art date
Application number
AT95941620T
Other languages
English (en)
Inventor
Paolo M Comoglio
Original Assignee
Dompe Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dompe Spa filed Critical Dompe Spa
Application granted granted Critical
Publication of ATE225183T1 publication Critical patent/ATE225183T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/4753—Hepatocyte growth factor; Scatter factor; Tumor cytotoxic factor II
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1833—Hepatocyte growth factor; Scatter factor; Tumor cytotoxic factor II
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2799/00—Uses of viruses
    • C12N2799/02—Uses of viruses as vector
    • C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
    • C12N2799/026—Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from a baculovirus

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
AT95941620T 1994-11-24 1995-11-22 Verwendung von hepatozyten-wachstumsfaktor zur induzierung der proliferation und differenzierung von hämatopoietischen zellen ATE225183T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ITMI942382A IT1271088B (it) 1994-11-24 1994-11-24 Uso di fattore di crescita degli epatociti per indurre la proliferazione e differenziazione di cellule emopoietiche
PCT/EP1995/004589 WO1996015802A1 (en) 1994-11-24 1995-11-22 Use of the hepatocyte growth factor to induce proliferation and differentiation of hemopoietic cells

Publications (1)

Publication Number Publication Date
ATE225183T1 true ATE225183T1 (de) 2002-10-15

Family

ID=11369904

Family Applications (1)

Application Number Title Priority Date Filing Date
AT95941620T ATE225183T1 (de) 1994-11-24 1995-11-22 Verwendung von hepatozyten-wachstumsfaktor zur induzierung der proliferation und differenzierung von hämatopoietischen zellen

Country Status (12)

Country Link
US (1) US5968501A (de)
EP (1) EP0793503B1 (de)
JP (1) JP3874024B2 (de)
AT (1) ATE225183T1 (de)
AU (1) AU707259B2 (de)
CA (1) CA2205914C (de)
DE (1) DE69528473T2 (de)
DK (1) DK0793503T3 (de)
ES (1) ES2183890T3 (de)
IT (1) IT1271088B (de)
PT (1) PT793503E (de)
WO (1) WO1996015802A1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2519975C (en) * 2003-04-08 2013-07-02 Yeda Research And Development Co. Ltd Stem cells having increased sensitivity to a chemoattractant and methods of generating and using same
FR2853551B1 (fr) 2003-04-09 2006-08-04 Lab Francais Du Fractionnement Formulation stabilisante pour compositions d'immunoglobulines g sous forme liquide et sous forme lyophilisee
WO2006040615A2 (en) * 2003-06-11 2006-04-20 Jan Remmereit Differenciation of stem cells for therapeutic use
JP2007528365A (ja) * 2004-03-09 2007-10-11 株式会社 東北テクノアーチ 肝細胞増殖因子を含有する血管分化誘導促進剤
JP4797186B2 (ja) * 2004-10-08 2011-10-19 剛史 汐田 末梢血中への造血幹細胞動員剤
US9664671B2 (en) 2012-07-24 2017-05-30 Nissan Chemical Industries, Ltd. Culture medium composition and method of culturing cell or tissue using thereof
US10017805B2 (en) 2012-08-23 2018-07-10 Nissan Chemical Industries, Ltd. Enhancing ingredients for protein production from various cells
EP2987852A4 (de) * 2013-04-17 2016-09-07 Nissan Chemical Ind Ltd Medienzusammensetzung und verfahren zur produktion von erythrozyten damit
US11628190B2 (en) * 2015-08-28 2023-04-18 University Of South Florida Plasma derived from human umbilical cord blood for the treatment of neurodegenerative disorders

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2564486B2 (ja) * 1986-07-14 1996-12-18 修治 橋本 肝細胞増殖因子
US5763266A (en) * 1989-06-15 1998-06-09 The Regents Of The University Of Michigan Methods, compositions and devices for maintaining and growing human stem and/or hematopoietics cells
US5362716A (en) * 1989-12-27 1994-11-08 The United States Of America As Represented By The Department Of Health And Human Services Methods for stimulating hematopoietic progenitors using hepatocyte growth factor and lymphokines
DE69133492T2 (de) * 1990-06-11 2006-08-10 Nakamura, Toshikazu Rekombinanter menschlicher Hepatozytwachstumsfaktor und Verfahren zu seiner Herstellung
ATE178354T1 (de) * 1990-07-13 1999-04-15 Snow Brand Milk Products Co Ltd Plasmid das für die aminosäuresequenz von tcf-ii kodierende dns enthalt, transformierte zelle und produktion einer physiologisch aktiven substanz mit ihrer verwendung
JP3395181B2 (ja) * 1991-07-26 2003-04-07 東レ株式会社 造血幹細胞増加剤
US5328837A (en) * 1992-05-18 1994-07-12 Genentech, Inc. Hepatocyte growth factor protease domain variants
US5599703A (en) * 1993-10-28 1997-02-04 The United States Of America As Represented By The Secretary Of The Navy In vitro amplification/expansion of CD34+ stem and progenitor cells

Also Published As

Publication number Publication date
ITMI942382A1 (it) 1996-05-24
AU707259B2 (en) 1999-07-08
DE69528473T2 (de) 2003-07-10
JP3874024B2 (ja) 2007-01-31
WO1996015802A1 (en) 1996-05-30
IT1271088B (it) 1997-05-26
PT793503E (pt) 2003-02-28
CA2205914C (en) 2009-04-07
US5968501A (en) 1999-10-19
CA2205914A1 (en) 1996-05-30
EP0793503B1 (de) 2002-10-02
AU4299696A (en) 1996-06-17
ITMI942382A0 (it) 1994-11-24
ES2183890T3 (es) 2003-04-01
DE69528473D1 (de) 2002-11-07
EP0793503A1 (de) 1997-09-10
JPH10509951A (ja) 1998-09-29
DK0793503T3 (da) 2003-02-03

Similar Documents

Publication Publication Date Title
ATE270323T1 (de) Zusammensetzungen und verfahren zur stimulierung der proliferation und der differenzierung von menschlichen fetalen und erwachsenen pankreatischen zellen ex vivo
ATE347585T1 (de) In-vitro wachstum von langerhans'schen inseln und ihre verwendungen
DK0549774T3 (da) Anvendelse af porøst calciumcarbonat som bærermateriale for in vitro cellekulturer
DK1545565T3 (da) Sammensætninger, som indeholder mitotisk inaktiverede allogene fibroblaster og keratinocyter til anvendelse i regenerering af væv
BR0210599A (pt) Uso de monóxido de carbono, método para manutenção de uma célula animal in vitro, artigo de manufatura, bem como meio celular estéril
ATE399563T1 (de) Extrazelluläre, gdf-5 enthaltende matrix zur induktion oder verstärkung der chondrogenese
WO2000006704A3 (en) Hematopoietic cell composition for use in transplantation
DE60016775D1 (de) Hybride matrizen und gemische davon
ATE237633T1 (de) Analogen des keratinozytenwachstumfaktors
DE69430059D1 (de) Freisetzung und Mobilisierung hämatopoietischer Zellen
DE69528473D1 (de) Verwendung von hepatozyten-wachstumsfaktor zur induzierung der proliferation und differenzierung von hämatopoietischen zellen
ATE145556T1 (de) Verwendung von interleukin-4 zur behandlung der festen tumoren
ATE514771T1 (de) Haartransplantation
ATE444078T1 (de) Menschliches wachstumshormon zur stimulierung der mobilisierung pluripotenter hämapoietischer stammzellen
DE602004022145D1 (de) Von monozyten stammende multipotente zelle momc
ATE290789T1 (de) Verwendungsmethoden von einkernigen phagozyten zur förderung der axonalen regeneration
DE69526395D1 (de) Verwendung von Interferon-gamma zur Vermeidung der Proliferation und Differenzierung der primitiven Hämapoietischen Vorläuferzellen
SE8500470L (sv) Kompositioner for kosmetiskt, helso- och kroppsbevarande bruk
CA2517140A1 (en) Use of pc-cell derived growth factor (pcdgf) for increasing the proliferation of b cells
ATE124262T1 (de) Verwendung von wirtszellphospholipiden zur hemmung bakterieller besiedlung.
ATE191501T1 (de) Verwendung von hepatocyten-wachstumsfaktoren zur herstellung eines vermehrungssystems für hematopoietische stammzellen
DE69434968D1 (de) Tiermodell für hepatitis-virus infektion
PT765398E (pt) Populacao de celulas enriquecedoras em progenitores mieloides e linfoides e metodos de as fazer e utilizar
DE69837212D1 (de) Verfahren zur induzierung der osteoblastischen differenzierung der zellen des menschlichen extramedullären fettgewebes
DE50004024D1 (de) Verwendung von treosulfan zur konditionierung von patienten vor knochenmarktransplantation oder blutstammzelltransplantation

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0793503

Country of ref document: EP

EEIH Change in the person of patent owner